These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 14508832)

  • 21. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
    J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
    Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
    Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
    Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
    Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
    Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
    Lepourcelet M; Tou L; Cai L; Sawada J; Lazar AJ; Glickman JN; Williamson JA; Everett AD; Redston M; Fox EA; Nakatani Y; Shivdasani RA
    Development; 2005 Jan; 132(2):415-27. PubMed ID: 15604097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
    Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
    Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
    Mitsuhashi N; Kobayashi S; Doki T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Miura S; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e189-97. PubMed ID: 18466288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.